you can't possibly compare Linn Energy to Kinder Morgan. they do completely different things. LNCO and SDRL are drillers and are radically more exposed to the price of oil/gas than KMI.
the RAS forum is the most uniquely bizarre forum in all of yahoo-dom. it appears to be 500 name-calling bears and their associated aliases against one lone articulate bull. this forum seems to be more about 1 person than 1 publicly traded company. i'm not sure what has created this perpetual environment. it never seems to change over the years, no matter what the share price is doing. or maybe it's simply there are a lot of share holders still stuck with shares above $80. if i was one of them i'd be disgusted too. as it is, i'm not too thrilled owning RAS at $7.55 (since june 2013). what i'd like to know is the profile of the Foulger bashers... are they stuck in a perpetual hell of being long RAS above $20.... $40.... $80.... etc? are they shorts? is it really just 5 people with 64 aliases? just exactly #$%$ is going on?
MLPs don't trade on P/E ratios. they trade on DCF. ETE's DCF year over year (1st quarter) went from $199 to $321 million . DCF, as adjusted, per unit was $0.59 in the 1st quarter. that's up 69% compared to the 1st quarter a year ago. the distribution is up 37% year over year.
post earnings: Credit Suisse reiterates a $52 target price for KMI. post earnings: Morningstar reiterates $43 "fair value" on KMI. post earnings: S&P gives KMI a $45 twelve month target price. those are the only post earnings reports i have seen.
i bet there were very few individuals selling WMB today. I think what happened was a sell off in the ETFs holding WMB.
UBS reiterates a Buy rating on New Residential Investment (NYSE: NRZ), and raises the price target to $21.00 (from $17.00), to reflect expectations of a successful acquisition strategy. Analyst Matthew Howlett says that after the HLSS acquisition, NRZ is the go-to partner for MSR acquisitions.
Howlett commented, "We are raising our earnings estimates in 2015 and 2016 and our price target to $21 to reflect our view that NRZ will successfully execute on its strategy of excess MSRs acquisition and call rights monetization, while receiving a healthy yield boost from servicer advances. We believe the REIT structure and sagacious management team has NRZ positioned to continue to accretively acquire servicing assets and non-agency securities and bonds to collapse deals. After the HLSS acquisition, NRZ is the go-to partner for MSR acquisitions with both Nationstar (NSM) and Ocwen (OCN), which we believe will lead to bulk and flow excess MSRs supporting near-term earnings growth and long-term stability. Our revised estimates represent 25% YoY growth in 2015 and 9% YoY growth in 2016, with a quarterly dividend increase to $0.50 per share in 1Q16E."
they won't cut the dividend this quarter. with repayments they'll probably cover the dividend this quarter. they've never cut the dividend, so even if they miss coverage for a quarter or two, they're not likely to cut the dividend.
CELG has been in a 6 month consolidation and was beginning to move prior to buying RCPT. the ave target price for CELG was $146 prior to the RCPT deal. my shot-in-the-dark guess is we won't see $120 again without a huge broad market sell off or bad news on an individual drug.
FSC is such a horror show. BDCs are risky enough by nature, so why dabble in one that has chronically under performed w/ poor management? even BDCs with relatively successful management (TCRD, PNNT) are light-years below NAV. i'll never go near FSC again. there's just no need to when there are vastly superior BDCs available.
TRGP pops every time there's a merger or "almost merger" announced. today MWE was acquired and TRGP pops. back on june 22 when the ETE/Wmb news broke, TRGP was up $4 on that day. so it's just further indication TRGP is a definite take out target.
Kelcy is super rich, but that is an astonishing amount of moo-lah. that should put a serious floor in the unit price in the event of any market sell off.
rpatel010... that's why i said "good chance to pop between now and the end of the year." any correction in CELG will be short-lived.. i bought it $89 and i'll sell it sometime in the relatively distant future
KBW is one of the few, well-known, financial services that offer broad, in depth coverage of BDCs. they also hold conferences specifically for BDCs. now... to your question, "should we care?" my answer would be, "somewhat."
we've basically had 7 months of consolidation with CELG while IBB has been up 20%. based on that you'd think CELG has a good chance to pop between now and the end of the year.
from their home page click "learn more." then in the upper right corner click of the 3 small parallel lines. that will open a drop down menu. click on "funds." then click on "PNNT" (it's the first of 3 boxes that appear on the page). then click on "investor relations." then click on "documents," for press releases, presentations and SEC filings. OR click on "research" for the dividend history.